Entity Common Stock, Shares Outstanding of BioNexus Gene Lab Corp from 31 Mar 2019 to 18 Aug 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
BioNexus Gene Lab Corp quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 31 Mar 2019 to 18 Aug 2025.
  • BioNexus Gene Lab Corp Entity Common Stock, Shares Outstanding for the quarter ending 18 Aug 2025 was 1,796,597.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

BioNexus Gene Lab Corp Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 1,796,597 18 Aug 2025 10-Q 18 Aug 2025 2025 Q2
Q1 2025 1,796,597 -15,871,066 -90% 15 May 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 17,967,663 +300,000 +1.7% 31 Dec 2024 10-K/A 29 Apr 2025 2024 FY
Q2 2024 17,967,663 +269,114 +1.5% 14 Aug 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 17,667,663 -156,050,489 -90% 08 May 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 17,667,663 -156,050,489 -90% 31 Dec 2023 10-K/A 31 May 2024 2023 FY
Q2 2023 17,698,549 -156,019,603 -90% 14 Aug 2023 10-Q/A 31 May 2024 2023 Q2
Q1 2023 173,718,152 +2,500,000 +1.5% 31 Mar 2023 10-K 31 Mar 2023 2022 FY
Q4 2022 173,718,152 31 Dec 2022 10-K/A 31 May 2024 2022 FY
Q3 2022 173,718,152 +2,500,000 +1.5% 11 Nov 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 173,718,152 +2,500,000 +1.5% 12 Aug 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 171,218,152 0 0% 30 Mar 2022 10-K 06 Apr 2022 2021 FY
Q3 2021 171,218,152 +68,487,261 +67% 09 Nov 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 171,218,152 +68,487,261 +67% 09 Aug 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 171,218,152 +68,487,261 +67% 30 Mar 2021 10-K 30 Mar 2021 2020 FY
Q3 2020 102,730,891 -6,645,334 -6.1% 03 Nov 2020 10-Q/A 09 Nov 2020 2020 Q3
Q2 2020 102,730,891 +28,103,333 +38% 03 Aug 2020 10-Q 11 Aug 2020 2020 Q2
Q1 2020 102,730,891 +28,103,333 +38% 30 Mar 2020 10-K 31 Mar 2020 2019 FY
Q3 2019 109,376,225 08 Nov 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 74,627,558 07 Aug 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 74,627,558 31 Mar 2019 10-Q 15 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.